In a video, an analyst lays out the technical case for a major Canadian commodity player that enjoys 2-year price highs for its product while volumes expand.
A recent fintech IPO sets up for a huge move. Analysts are finally turning on to the story.
A high flying medical diagnostics company has investors scared of falling revenue after COVID vaccines become available. The reaction was a strong sell off and now the stock is back on track towards its all time highs.
A Dutch semi manufacturer may have secretly been awarded a contract to supply chips for space exploration. We see large call buyers expecting a bounce in the company’s shares.
With more than 25% short interest, this $40 Billion US mortgage provider could be heading for a 25% gain in coming months.
Large buyers of options accentuate the breakout in this stock today. As an emerging leader in AI for autonomous driving, the company has a longer term appeal for ESG and technology focused investors.
Domestic Chinese travel has recovered to levels seen before COVID. A recovery of Asian travel is likely to follow. Two stocks stand to revalue on an increase in mobility trends.
Back in September, we mentioned this stock on news about its partnership with Microsoft. Since then it has pulled back mainly due to rotation from Growth to Value. We believe it has now bottomed and presenting a buying opportunity.
We are following up on a recent IPO idea published on our telegram channel. This Medtech company looks towards a post COVID expansion in Europe and Asia.
The move from Growth stocks to Value names has been quick and decisive. We look at a big name tech stock to take advantage of a rotation back into growth.
This information is not an individual investment recommendation, and the financial instruments or transactions mentioned in it may not correspond to your investment profile and investment goals (expectations). It is your task to determine whether a financial instrument or transaction matches your interests, investment objectives, investment horizon and acceptable risk level. AVC Adisvory, Inc. and its affiliates are not liable for possible losses in case of making transactions or investing in the financial instruments mentioned in this information, and do not recommend using this information as the only source of information when making an investment decision.
